SHARECARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.81 USD | +9.00% |
|
+23.66% | -25.00% |
| Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
| Apr. 01 | BTIG Research Downgrades Sharecare to Neutral From Buy | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 454.5 | 1,522 | 565.6 | 380.6 | 293.4 | - | - |
| Enterprise Value (EV) 1 | 454.5 | 1,252 | 565.6 | 252.9 | 261.3 | 265.8 | 251.9 |
| P/E ratio | -0.37 x | -15 x | -4.71 x | -3 x | -2.66 x | -2.75 x | - |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.38 x | 3.69 x | 1.28 x | 0.85 x | 0.67 x | 0.62 x | 0.56 x |
| EV / Revenue | 1.38 x | 3.03 x | 1.28 x | 0.57 x | 0.6 x | 0.56 x | 0.48 x |
| EV / EBITDA | - | 46.3 x | 35.9 x | 15.4 x | 15.9 x | 9.41 x | 4.33 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | 0.88 x | 0.72 x | 0.71 x | 0.68 x |
| Nbr of stocks (in thousands) | 43,125 | 339,034 | 353,520 | 352,424 | 362,199 | - | - |
| Reference price 2 | 10.54 | 4.490 | 1.600 | 1.080 | 0.8100 | 0.8100 | 0.8100 |
| Announcement Date | 4/9/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 328.8 | 412.8 | 442.4 | 445.3 | 437 | 474.2 | 527.8 |
| EBITDA 1 | - | 27.03 | 15.78 | 16.48 | 16.43 | 28.24 | 58.14 |
| EBIT 1 | - | -85.44 | -139.3 | -136 | -96.82 | -86.1 | -18.4 |
| Operating Margin | - | -20.7% | -31.5% | -30.54% | -22.15% | -18.16% | -3.49% |
| Earnings before Tax (EBT) 1 | - | -87.15 | -119.7 | -130.2 | -98.12 | -83.7 | -22.4 |
| Net income 1 | - | -85 | -118.7 | -128.5 | -98.04 | -83.49 | -23.65 |
| Net margin | - | -20.59% | -26.83% | -28.86% | -22.43% | -17.61% | -4.48% |
| EPS 2 | -28.48 | -0.3000 | -0.3400 | -0.3600 | -0.3050 | -0.2950 | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 4/9/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 105.6 | 118.5 | 100.7 | 103.8 | 114.6 | 123.3 | 116.3 | 110.4 | 113.3 | 105.3 | 101.3 | 102.7 | 110.6 | 115.9 |
| EBITDA 1 | 7.903 | 5.355 | 0.15 | 2.135 | 7.225 | 4.594 | 2.104 | 3.816 | 9.603 | 2.984 | 1.331 | 2.414 | 4.03 | 5.18 |
| EBIT 1 | -29.52 | -39.13 | -9.728 | -35.64 | -25.48 | -27.64 | -36.65 | -34.14 | -29.72 | -35.45 | -29.73 | -29 | -28.32 | -27.62 |
| Operating Margin | -27.95% | -33.01% | -9.66% | -34.33% | -22.23% | -22.42% | -31.52% | -30.94% | -26.23% | -33.68% | -29.34% | -28.23% | -25.6% | -23.83% |
| Earnings before Tax (EBT) 1 | -43.57 | 8.018 | -38.21 | -29.25 | -28.09 | -24.15 | -34.97 | -35.58 | -25.41 | -34.25 | -28.13 | -27.47 | -26.84 | -26.17 |
| Net income 1 | -43.12 | 9.617 | -38.2 | -29.02 | -27.36 | -24.12 | -34.66 | -35.14 | -24.45 | -34.24 | -27.88 | -27.22 | -26.59 | -25.92 |
| Net margin | -40.82% | 8.11% | -37.93% | -27.96% | -23.87% | -19.57% | -29.8% | -31.85% | -21.58% | -32.53% | -27.51% | -26.5% | -24.03% | -22.36% |
| EPS 2 | -0.1300 | 0.0200 | -0.1100 | -0.0800 | -0.0800 | -0.0700 | -0.1000 | -0.1000 | -0.0700 | -0.1000 | -0.0800 | -0.0800 | -0.0750 | -0.0750 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 3/31/22 | 5/12/22 | 8/10/22 | 11/10/22 | 3/29/23 | 5/10/23 | 8/9/23 | 11/9/23 | 3/28/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 271 | - | 128 | 32 | 27.5 | 41.4 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | -27% | -19.1% | -9.92% | -5.73% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | - | 1.220 | 1.130 | 1.140 | 1.200 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 4/9/21 | 3/31/22 | 3/29/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.81
USD
Average target price
1.5
USD
Spread / Average Target
+85.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 293M | |
| +11.17% | 322B | |
| +24.75% | 216B | |
| +2.41% | 149B | |
| +10.65% | 56.27B | |
| +8.71% | 32.13B | |
| -4.57% | 27.45B | |
| +103.03% | 22.62B | |
| +20.22% | 19.55B | |
| +0.04% | 14.61B |
- Stock Market
- Equities
- SHCR Stock
- Financials Sharecare, Inc.
